Masitinib

From WikiMD.org
Jump to navigation Jump to search

Masitinib (pronunciation: ma-si-ti-nib) is a tyrosine kinase inhibitor that is primarily used in the treatment of certain types of cancer and inflammatory diseases. It is a selective inhibitor of the c-Kit, PDGFR and Lyn kinases, which are involved in various cellular processes such as cell growth, differentiation, and survival.

Etymology

The name "Masitinib" is derived from the chemical name "N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-methylpiperazin-1-yl)piperidine-1-carboxamide". The term "Masitinib" is a nonproprietary name used to identify this specific chemical compound.

Usage

Masitinib is used in the treatment of mastocytosis, a rare disease characterized by an excessive accumulation of mast cells in the body. It is also used in the treatment of certain types of gastrointestinal stromal tumors (GISTs), which are a type of cancer that originates in the digestive tract. In addition, Masitinib is being investigated for its potential use in treating Alzheimer's disease, multiple sclerosis, and asthma.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski